190 related articles for article (PubMed ID: 34877075)
21. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
22. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for positive margins after wide local excision of cutaneous squamous cell carcinoma.
Stewart TJ; Saunders A
J Dermatolog Treat; 2018 Nov; 29(7):706-708. PubMed ID: 29448853
[TBL] [Abstract][Full Text] [Related]
24. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia.
Grover P; Flukes S; Jacques A; Leedman S; Lindsay A; White R; Friedland P; Gurfinkel R; Lim AM
Intern Med J; 2022 Jun; 52(6):944-951. PubMed ID: 34800329
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
Upton M; Kita A; Scapa J; St John M
Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
[TBL] [Abstract][Full Text] [Related]
28. Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective.
Wilmas KM; Nguyen QB; Patel J; Silapunt S; Migden MR
Future Oncol; 2021 Dec; 17(35):4971-4982. PubMed ID: 34608809
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients.
Oh Y; Kim J; Zheng Z; Kim SK; Chung KY; Roh MR
J Dermatol; 2020 Jan; 47(1):72-77. PubMed ID: 31674043
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma.
McLean LS; Lim AM; Webb A; Cavanagh K; Thai A; Magarey M; Fox C; Kleid S; Rischin D
Front Oncol; 2021; 11():796197. PubMed ID: 35117997
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
32. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
Farberg AS; Fitzgerald AL; Ibrahim SF; Tolkachjov SN; Soleymani T; Douglas LM; Kurley SJ; Arron ST
Dermatol Ther (Heidelb); 2022 Feb; 12(2):267-284. PubMed ID: 34994967
[TBL] [Abstract][Full Text] [Related]
33. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma.
Brancaccio G; Briatico G; Pellegrini C; Rocco T; Moscarella E; Fargnoli MC
Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021166S. PubMed ID: 34877074
[TBL] [Abstract][Full Text] [Related]
35. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
36. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
[TBL] [Abstract][Full Text] [Related]
37. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
39. Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck.
Varra V; Smile TD; Geiger JL; Koyfman SA
Curr Treat Options Oncol; 2020 Apr; 21(5):37. PubMed ID: 32328817
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A; Cecchi F; Tanda ET; Croce E; Gili R; Arecco L; Spagnolo F; Queirolo P
Front Oncol; 2021; 11():733917. PubMed ID: 34513710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
